Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Income from Continuing Operations (2019 - 2026)

Profound Medical has reported Income from Continuing Operations over the past 7 years, most recently at 35188000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 811.3% year-over-year to 35188000.0; the TTM value through Dec 2025 reached 813000.0, up 102.92%, while the annual FY2025 figure was 800000.0, 102.88% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 35188000.0 at Profound Medical, up from 7956000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 35188000.0 in Q4 2025 and troughed at 50996000.0 in Q4 2021.
  • A 5-year average of 5712150.0 and a median of 8000.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: crashed 336.34% in 2021 and later skyrocketed 811.3% in 2025.
  • Year by year, Income from Continuing Operations stood at 50996000.0 in 2021, then increased by 6.97% to 47443000.0 in 2022, then decreased by 0.59% to 47722000.0 in 2023, then surged by 89.63% to 4947000.0 in 2024, then skyrocketed by 811.3% to 35188000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for PROF at 35188000.0 in Q4 2025, 7956000.0 in Q3 2025, and 15695000.0 in Q2 2025.